Previous 10 | Next 10 |
2024-02-06 21:05:23 ET Edwards Lifesciences Corporation (EW) Q4 2023 Earnings Conference Call February 06, 2024, 05:00 PM ET Company Participants Mark Wilterding - Investor Relations and Treasurer Bernard Zovighian - Chief Executive Officer Scott Ullem - Chief Fi...
2024-02-06 16:20:14 ET More on Edwards Lifesciences Edward Lifesciences: Still Not A Buy But Getting Closer Edwards Lifesciences: Undervalued With A Substantial Upside Potential Edwards Lifesciences Q4 2023 Earnings Preview Edwards stock jumps 8% on FDA appro...
Algoma Steel Group Inc. (ASTL) is expected to report for Q3 2024 CTS Corporation (CTS) is expected to report for Q4 2023 Xylem Inc. New (XYL) is expected to report $0.96 for Q4 2023 TIM S.A. American Depositary Shares (Each representing 5) (TIMB) is expected to report for Q4 2023 ...
2024-02-06 01:10:00 ET Summary Some big tech results fizzled, but there were two standouts last week. Nine S&P 500® companies have outlier earnings dates this week - MCD, IEX, EW, MAA, MCK, HSY, COP, TROW, CTLT. 1,558 companies are expected to report during the second...
2024-02-05 17:05:31 ET More on Edwards Lifesciences Edward Lifesciences: Still Not A Buy But Getting Closer Edwards Lifesciences: Undervalued With A Substantial Upside Potential Seeking Alpha’s Quant Rating on Edwards Lifesciences Read the full artic...
2024-02-02 12:20:25 ET More on Edwards Lifesciences Edward Lifesciences: Still Not A Buy But Getting Closer Edwards Lifesciences: Undervalued With A Substantial Upside Potential Edwards gets FDA okay for Evoque tricuspid valve replacement system Edwards Lifes...
2024-02-02 10:51:42 ET More on Edwards Lifesciences Edward Lifesciences: Still Not A Buy But Getting Closer Edwards Lifesciences: Undervalued With A Substantial Upside Potential Edwards Lifesciences provides 2024 outlook, OKs additional $1B stock buyback Edwa...
Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S. Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation (TR). The EVOQUE system is indicat...
2024-01-31 15:33:55 ET More on Boston Scientific, Stryker, etc. Boston Scientific Corporation (BSX) Q4 2023 Earnings Call Transcript Stryker Corporation (SYK) Q4 2023 Earnings Call Transcript Boston Scientific: Portfolio Updates Driving Top-Line Growth Boston...
2024-01-31 08:05:00 ET Summary The Ithaka Group is an independent investment boutique that specializes in managing high-quality, concentrated growth equity portfolios. During the fourth quarter Ithaka’s portfolio outperformed in a strong market, rising 18.4% vs the R1G risi...
News, Short Squeeze, Breakout and More Instantly...
Edwards Lifesciences Corporation Company Name:
EW Stock Symbol:
NYSE Market:
Edwards Lifesciences Corporation Website:
Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2024 after the market closes on Wednesday, July 24, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877)...
Edwards Lifesciences (NYSE: EW) today announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an early-stage transcatheter mitral valve replacement (TMVR) company, following its initial investment in 2017. Since that time, Innovalve has demonstrated progress in its program wi...
2024-07-08 19:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...